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Abstract: Biofilms are surface-associated microbial communities known for their increased resistance
to antimicrobials and host factors. This resistance introduces a critical clinical challenge, particularly in
cases associated with implants increasing the predisposition for bacterial infections. Preventing such
infections requires the development of novel antimicrobials or compounds that enhance bactericidal
effect of currently available antibiotics. We have synthesized and characterized twelve novel silver(I)
cyanoximates designated as Ag(ACO), Ag(BCO), Ag(CCO), Ag(ECO), Ag(PiCO), Ag(PICO) (yellow
and red polymorphs), Ag(BIHCO), Ag(BIMCO), Ag(BOCO), Ag(BTCO), Ag(MCO) and Ag(PiPCO).
The compounds exhibit a remarkable resistance to high intensity visible light, UV radiation and
heat and have poor solubility in water. All these compounds can be well incorporated into the
light-curable acrylate polymeric composites that are currently used as dental fillers or adhesives
of indwelling medical devices. A range of dry weight % from 0.5 to 5.0 of the compounds was
tested in this study. To study the potential of these compounds in preventing planktonic and biofilm
growth of bacteria, we selected two human pathogens (Gram-negative Pseudomonas aeruginosa and
Gram-positive Staphylococcus aureus) and Gram-positive environmental isolate Bacillus aryabhattai.
Both planktonic and biofilm growth was abolished completely in the presence of 0.5% to 5% of the
compounds. The most efficient inhibition was shown by Ag(PiCO), Ag(BIHCO) and Ag(BTCO).
The inhibition of biofilm growth by Ag(PiCO)-yellow was confirmed by scanning electron microscopy
(SEM). Application of Ag(BTCO) and Ag(PiCO)-red in combination with tobramycin, the antibiotic
commonly used to treat P. aeruginosa infections, showed a significant synergistic effect. Finally,
the inhibitory effect lasted for at least 120 h in P. aeruginosa and 36 h in S. aureus and B. aryabhattai.
Overall, several silver(I) cyanoximates complexes efficiently prevent biofilm development of both
Gram-negative and Gram-positive bacteria and present a particularly significant potential for
applications against P. aeruginosa infections.
Keywords: Biofilm, antimicrobial; Pseudomonas aeruginosa; Staphylococcus aureus; Silver (I)
coordination polymers; cyanoximes; thermal stability; polymeric composites; mechanical strength;
density and porosity; leaching studies
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1. Introduction
Healthcare-associated infections are becoming increasingly prevalent in the United States.
According to the 2014 report from the Center for Disease and Prevention (CDC), the estimated
burden of nosocomial infections was 722,000 cases leading to about 75,000 fatalities. A significant
number of such infections are commonly associated with implanting surgical devices. These infections
are increasingly difficult to treat due to continuously growing prevalence of antibiotic resistant bacteria
in hospital settings and lead to considerable morbidity and healthcare costs [1]. Pathogenic bacteria
usually enter the surgical site during operative procedures or infect the wounds post-surgically [2]. Such
surgical implant infections are caused by diverse species of bacteria, including species of Staphylococcus,
Streptococcus and Pseudomonas genera [3]. Staphylococcus is considered the leading etiologic agent
of implant-associated infections [4]. Device-related infections caused by S. aureus and S. epidermidis
account for 50–60% of the cases [5]. P. aeruginosa represents a particular challenge due its antibiotic
resistance (reviewed in Reference [6]) and ability to colonize and form biofilms on diverse surfaces,
including those of devices, such as cardiac pacemakers, defibrillators and prosthetic cardiac valves [7].
Pseudomonas infections occur in about 4% of the estimated one million patients receiving implants each
year [5]. In 2017, the World Health Organization (WHO) has listed P. aeruginosa and S. aureus among
priority pathogens that require development of new antibiotics (WHO news release, 2017).
The development of implant-associated infections commonly involves adhesion of bacterial
pathogens to the surface of an implant and formation of biofilms. The National Institutes of Health
(NIH) reported that among all bacterial and chronic bacterial infections, 65% and 80%, respectively, are
associated with biofilm formation. Biofilms are microbial communities that grow on surfaces. They are
usually embedded into self-produced extracellular polymeric matrices, including polysaccharides,
proteins and DNA. Bacterial biofilms are known for increased resistance to antibiotics, antimicrobials
and host immune responses [8,9]. The increased biofilm resistance introduces a particularly critical
clinical challenge in case of implant-associated infections, since managing such infections is difficult
due to requirement of prolonged antibiotic therapy. In case this therapy fails, surgical interventions to
remove the infected devices are required, which are risky for patient health condition and costly [10,11].
Therefore, there is a critical need in better alternatives and the development of novel infection-prevention
strategies and antibacterial agents [3].
Application of metals, including silver (Ag), for treating human diseases is a vigorously expanding
area [12,13]. From the time of Hippocrates, Ag has been known to exhibit a broad spectrum of
antibacterial properties [14]. Strong bacteriostatic and bactericidal effects of Ag are generally explained
by its interactions with bacterial DNA and inactivation of bacterial respiration enzymes [15]. In addition,
interaction with Ag ions may cause generation of reactive oxygen species [16–18]. Disturbance of
membrane permeability and inhibition of transcription and translations have also been reported [19,20].
There is also evidence that silver nanoparticles (AgNPs) directly interact with the cell surface, penetrating
the cell membranes and causing leakage and eventually cell death [21,22]. Due to the increasing
prevalence of multidrug resistant bacteria, applications of Ag as an antimicrobial have become of
profound interest, particularly considering low toxicity of Ag to human cells and tissues [23]. Recent
studies showed that Ag exhibits antibacterial activity against both planktonic (free swimming) and
biofilm bacteria [24–26]. Silver reduces infection rates when used to coat surfaces of various implants,
such as urinary and central venous catheters [27–29] and ventilator endotracheal tubes [30]. However,
despite a strong potential of Ag for clinical applications, there are several challenges. The biggest
challenge for most Ag(I) inorganic compounds with antimicrobial properties is a reduction of metal
cation to elemental Ag(0) upon exposure to light and heat [31,32]. Other challenges include the
chemical reactivity of Ag(I) compounds with unsaturated organic compounds.
For a number of years, we have been investigating Ag complexes with cyanoximes—a new class
of the oxime-based versatile ampolydentate ligands [33,34] with the general formula NC-C(N=OH)-R,
where R is electron withdrawing group [35,36]. The main purpose of this ongoing work is to study
the effect of combination of the aforementioned biological properties of Ag with a well-established
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spectrum of biological activities of cyanoximes. The latter include growth-regulating [37,38] and
antimicrobial [39–41] properties. We initiated synthesis and characterization of structures and
properties of the new family of silver cyanoximates (reviewed in Reference [42]) and performed
a preliminary assessment of their antimicrobial activity [43], followed by their further detailed
characterization
[44]. In the most recent work, we obtained two previously unknown
AgL
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2. Experimental: Materials and Methods
2.1. Chemicals and Instrumentation
All solvents and basic chemicals, such as AgNO3 (≥99.0%), were reagent grade (Sigma Aldrich,
St. Louis, MO, USA) and used without further purification. The cyanoximes used in this study
(Scheme 1) were obtained in 2–5 g quantities according to reported procedures [43]. Identification and
purity of ligands were confirmed by the elemental analyses on C, H, N content (Atlantic Microlab,
Norcross, GA, USA), TLC chromatography on silicagel Al-backed plates with UV-indicator (Merk) and
melting points measurements (Digimelt apparatus, without correction).
Chemical components of dental composites were obtained from Sigma Aldrich (St. Louis, MO,
USA): triethylene glycol dimethacrylate (TEGMA), diurethane dimethacrylate (UDMA), Bisphenol
A glycerolate dimethacrylate glycerol/phenol 1(Bis-GMA), silicagel (SiO2 ), as inert filler, hollow,
non-porous glass beads, camphorquinone (CPQ) 97%, ethyl 4-(dimethylamino) benzoate (EDBMA).
More specific information regarding these materials is shown in Table S1 and S2
Non-halogenated buffer solutions used in the leaching experiments were Trimethylol
Aminomethane (TRIS-Base ≥99.8%; 0.5 M) and 3-(4-Morpholino)propane sulfonic acid (MOPS)
with a useful buffering range of pH 7–9 and pH 6.5–7.9, respectively [46]. Both solid chemicals were
provided by Fisher BioReagents and both solutions were prepared according to standard laboratory
procedures in DDI-water, to a pH of 7.
Brain Heart Infusion broth (BHI) and Tryptic soy broth (TSB) were purchased from Teknova
(Hollister, CA, USA).
2.2. Inductively Coupled Plasma (ICP) Analysis on Ag Content
ICP analyses were carried by using the ICP-AES spectrometer (Varian Liberty, Palo Alto, CA, USA)
at wavelength of 328.068 nm for detection of Silver(I) ion. An instrument search window was set to
0.080 nm and 0.120 nm with the scan in either direction. Standards for ICP method were obtained from
Ricca (PAG1KN-100, Silver ICP Standard, 1 mL = 1 mg of Ag as 1000 ppm stock solution of AgNO3
in 3% Nitric Acid; Trace Element Analysis Grade, Ricca, Arlington, TX, USA). Standard solutions for
Silver(I) ions determination were calibrated at 50.00 ppm, 10.00 ppm, 5.00 ppm, 1.00 ppm, 0.10 ppm
concentrations in acidified double deionized (DDI) water. The latter was obtained by adding dropwise
1 M nitric acid into 1 L DDI water to pH 5.5.
2.3. Spectroscopy
The identity of the synthesized AgL complexes (L = cyanoximate anions from Scheme 1) was confirmed
by: (1) recording their IR-spectra (Bruker FT-ATR instrument, Billerica, MA, USA; 500–4000 cm−1 range
with 4 cm−1 resolution) and (2) recording their diffusion-reflectance spectra (Cary 100 Bio equipped
with PMT Labsphere integrating sphere; 350–800 nm range) and matching those with the previously
reported spectra [44,47]. Both types of spectra were obtained at room temperature.
2.4. Thermal Analysis (TA)
Solid samples of pure AgL in amounts of 6–30 mg were used for the thermogravimetric/ differential
scanning calorimetry (TG/DSC) measurements using the Q-600 thermal analyzer from TA Instruments
(TA, New Castle, DE, USA) (Figure S1). Complexes were heated under atmosphere of pure N2 from
30 to 1400 ◦ C with 10◦ /min rate in a T-ramping mode. Data were processed with the aid of TA Universal
Analysis software package and presented in Figures S2–S4.
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2.5. Optical Microscopy (OM)
Photographic images of the synthesized AgL complexes were obtained by using the Motic X300
microscope (Motic, Richmond, BC, Canada) at ×20 magnification and were used for the assessment of
homogeneity of these microcrystalline solids (Figure S5).
2.6. Synthesis of Ag(I) Cyanoximates
Preparation of twelve Silver(I) complexes of 1:1 composition that include cyanoxime anions
was accomplished using a modified straightforward one-pot two steps reaction [42–44,47,48]. Thus,
the deprotonated cyanoxime, obtained upon the addition of K2 CO3 to the HL (Scheme 1) forming
bright-yellow solution in water, received an aqueous solution of AgNO3 , which was added dropwise
at room temperature and intense stirring: (a) 2 HL + K2 CO3 = 2 KL + H2 O + CO2 ↑ and (b) KL +
AgNO3 = AgL ↓ + KNO3 .
Preparations of Ag(CCO), Ag(BIHCO) and two polymorphs of Ag(PiCO) – red and yellow – were
never previously reported and therefore, presented below.
2.7. Silver(I) α-Oximido-(2-pivaloyl)acetonitrile, Ag(PiCO), Red Form
To 10 mL solution of K(PiCO) at room temperature, prepared by addition of 0.112 g of K2 CO3 to
0.250 g of HPiCO with the aid of a sonicator, a stoichiometric amount of AgNO3 (0.275 g) was added
dropwise within a minute under stirring. Fibrous salmon-pink precipitate immediately forms. After
~10 min stirring the precipitate was filtered, washed with 5 mL of water and dried in a desiccator over
H2 SO4 (c). Yield: 95%; compound rapidly decomposes at ~150 ◦ C. Analytical data: for AgC7H9N2O2
calculated, (found): C – 32.21 (31.96); H – 3.48 (3.41); N – 10.73 (10.67).
2.8. Silver(I) α -Oximido-(2-pivaloyl)acetonitrile, Ag(PiCO), Yellow Form
Actual amounts of ingredients were the same as in previous preparation. To a hot (at ~90 ◦ C)
aqueous solution of in situ deprotonated with K2 CO3 PiCO- in 10 mL of water a stoichiometric amount
of AgNO3 was slowly added in the dark. Upon addition of a drop of silver nitrate solution turbidity of
Ag(PiCO) complex appears but slowly dissolves. Thus, watching for a complete dissolution of the
initial precipitate is the key for successful preparation of this polymorph. After all required amount of
AgNO3 was added, transparent yellow solution was left in the dark to cool off slowly within ~10 h.
Nice yellow blocks of the yellow polymorph of Ag(PiCO) appear in abundance. Yield 85%; complex
rapidly decomposes at 160–162 ◦ C. Analytical data: for AgC7 H9 N2 O2 calculated, (found): C – 32.21
(31.81); H – 3.48 (3.51); N – 10.73 (10.62).
Those polymorphs showed different colors (Figure S6), as well as different solubility in water and
organic solvents.
2.9. Silver(I) α -Oximido-(2-benzoimidazolyl)acetonitrile, Ag(BIHCO)
This yellow-greenish complex was obtained upon room temperature reaction between in situ
deprotonated ligand H(BIHCO) (0.250 g dissolved in 10 mL of acetonitrile) and KOH (0.065 g dissolved
in 2 mL of water) at 1:1 stoichiometric ratio. Resulting solution was filtered from small turbidity and
aqueous solution of AgNO3 (0.198 g in 5 mL) was added dropwise upon stirring. The Ag(BIHCO)
precipitate that formed immediately, was filtered, washed with 10 mL of water and then dried in
a desiccator charged with concentrated H2 SO4 . Yield: 90%. Analytical data: for AgC10 H5 N4 O2
calculated, (found): C – 37.41 (37.62); H – 1.57 (1.53); N – 17.45 (17.38). The complex is thermally stable
to 150 ◦ C.
2.10. Silver(I) α -Oximido-(1-cyano)acetonitrile, Ag(CCO)
This bright deep-yellow microcrystalline powder was obtained (pure) after precipitation of the
[ONC(CN)2]- anion with AgNO3 from the reaction mixture containing CH2(CN)2 and HNO2 during
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the synthesis. Precipitated after the synthesis complex was filtered, washed twice with 5 mL of cold
water and the dried in a vacuum desiccator over concentrated H2 SO4 . Yield: 96%. The Ag{ONC(CN)2}
decomposes in the range of 175–210 ◦ C. Thermally stable up to 140 ◦ C without any visible change.
Analytical data: for C3N3OAg calculated, (found): C – 17.84 (17.98); N – 20.81 (20.69).
The following twelve complexes have been prepared (listed with their commonly used
abbreviations): Silver(I) Nitrosodicyanomethanide – Ag(CCO); Silver(I) α-Oximino-(acetamide)
acetonitrile – Ag(ACO); Silver(I) α-Oximino-(ethylacetate)acetonitrile – Ag(ECO); Silver(I)
α-Oximino-(benzoyl)acetonitrile – Ag(BCO); Silver(I) α-Oximino(pivaloyl) acetonitrile – Ag(PiCO),
two polymorphs; Silver(I) α-Oximino-(N,N’-dimethylacetamide) acetonitrile – Ag(DCO); Silver(I)
α-Oximino-(2-benzothiazolyl)acetonitrile – Ag(BTCO); Silver(I) α-Oximino-(2-benzoxazole) acetonitrile
– Ag(BOCO); Silver(I) α-Oximino-(N-methyl-2-benzimidazole)acetonitrile – Ag(BIMCO); Silver(I)
α-Oximino-(2-benzimidazole)acetonitrile – Ag(BIHCO); Silver(I) α-Oximino-(N-piperidine-acetamide)
acetonitrile – Ag(PiPCO) and Silver(I) α-Oximino-(N-morpholyl-acetamide)acetonitrile – Ag(MCO).
Yields, physical properties and data of elemental analyses for AgL are presented in Tables S3 and S4.
3. Physico-Chemical Characterization of Silver(I) Cyanoximates and Acrylate Polymeric
Composited with Embedded Complexes
3.1. Characterization of AgL Using Spectroscopic Methods
Vibrational and electronic spectra were recorded for the initial protonated cyanoximes HL and for
the final Ag(I) cyanoximates.
3.2. IR-Spectroscopy
Spectra were obtained from thick mulls in Nujol and were placed between two 15 mm diameter
KBr disks using a Vertex 70 Bruker FT-IR spectrophotometer (Bruker, Billerica, MA, USA) set for
64 scans at 4 cm−1 resolution in the 4000–400 cm−1 range. Some neat samples powdery samples,
however, were recorded using the ATR method (Bruker R32 spectrophotometer, Bruker, Billerica, MA,
USA) when Nujol bands were obscuring bands of the CNO-fragment.
3.3. UV-Visible Spectroscopy
Spectra of diffused reflectance (SDR) were recorded from powders of solid AgL using Cary 100 Bio
spectrophotometer (Agilent, Santa Clara, CA, USA) equipped with the Labsphere accessory (Figure S7).
3.4. Preparation of Polymeric Mixtures Containing Ag(I) Cyanoximates
After thorough drying in a vacuum desiccator, fine powders of Ag(I) cyanoximates were mixed
with acrylate polymeric composite that has been modified for better flowability and handling to achieve
a final concentration of 0.5, 1, 2.5 and 5% by weight (w/w) (Table S2). Then 200 µL of each mixture was
added to the wells of 96-well transparent flat-bottom plates (Corning Inc., NY, USA) using a syringe
(Figures S9 and S10) and solidified using Spectrum curing light (Figures S8 and S11). Chlorhexidine®,
a cationic polybiguanide (bisbiguanide)—commonly used to treat gingivitis and periodontitis—was
applied at the same final concentrations and was used as a reference antimicrobial compound [49].
3.5. Solid Polymers Testing
Samples of acrylate-based polymeric composites were made as cylinders with ~1:1 ratio of length
to diameter. The Ag(ACO) complex was arbitrary chosen for testing. A flovable polymer mixture
(preparation of which was described above) was casted into 12 mm diameter and ~10–12 mm height
cut small PVC tubes. Then a standard in dental practice 400 nm bright light source was used for
the polymer curing. Samples were: (1) pure polymer, control; (2) polymer with 0.5 weigh % of the
Ag-cyanoximate; (3) polymer mixed with 5% weight of the Ag-cyanoximate.
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3.6. Mechanical Strength Testing
Strength of solid cylindrical samples of prepared polymers was measured using the instrument
shown in Figure S19. Mechanical testing under quasistatic compression of pure polymeric composite
and two samples with different amounts of embedded Ag-complexes (0.5% and 5% by weight) was
conducted with an Instron 3369 universal testing machine at a strain rate of 2.5 mm/min, using a 50 kN
load cell following testing procedures in the spirit of ASTM D1621−04a (Standard Test Method for
Compressive Properties of Rigid Cellular Plastics). Results are presented in Table 1.
Table 1. Summary of mechanical testing of studied polymeric composites with embedded silver(I)
cyanoximates.
Sample % w/w Solids

Compressive Modulus
(Young’s Modulus, MPa)

Strain at Break
(mm/mm)

Stress at Break
(MPa)

Polymer, no complex

810

0.072

87.801

Ag(ACO) 0.5% wt/wt%

72.970

0.032

2.233

Ag(ACO) 5.0% wt/wt%

42.211

0.019

0.801

3.7. Bulk Density
These measurements were carried out in order to evaluate the effect of addition of silver(I)
complexes on density of resulting polymer. Bulk densities (ρb) were calculated from the weight and the
physical dimensions of the samples. Skeletal densities (ρs) were determined with helium pycnometry
using a Micromeritics AccuPyc II 1340 instrument (Micromeritics, Norcross, GA, USA) depicted in
Figure S20. Data are shown in Table 2.
Table 2. Results of determination of densities and porosity of studied samples of acrylate polymeric
composites (averaged values).
Sample-% w/w Solids

Bulk Density,
ρb (g cm−3 ) a

Skeletal Density,
ρs (g cm−3 ) b

Porosity,
ρ (% Void Space) c

No metal complex, polymer,

1.103 ± 0.003

1.168 ± 0.005

5.565

Ag(ACO) 0.5% wt/wt%-run1

1.054 ± 0.050

1.156 ± 0.004

8.824

Ag(ACO) 5.0% wt/wt%-run1

1.020 ± 0.027

1.147 ± 0.002

11.072

a

Average of 2 samples; Single sample, average of 50 measurements; porosity, II = 100 × (ρs − ρb )/ρs.
b

c

3.8. Surface Area Measurements and Porosity of Composites
An attempt to determine the BET surface areas and possible pores sizes was made with an N2
sorption porosimetry at 77 K using a Micromeritics ASAP 2020 surface area and porosity analyzer
(Micromeritics, Norcross, GA, USA), which is shown in Figure S21 with results summarized in Table 2.
3.9. Leaching Experiments
Three Ag(I) complexes – Ag(CCO), Ag(ACO) and Ag(BTCO) were selected for testing Ag ions
leaching because these cyanoximes represent a range of hydrophilic and hydrophobic ligands used to
bind metal cations. These experiments consisted of five parts: (1) making bulk composite containing
each of the selected three Silver(I) cyanoximates at 5% w/w; (2) casting them into a form of 3 × 10 mm;
(3) curing the mixtures with light; (4) exposing the obtained solid pellets to non-halogenated buffers
(TRIS and MOPS) at pH~7; (5) taking aliquots every 30 min for 170 h and analyzing their content for
the presence of Ag ions using the ICP method. Further details of the experimental design of leaching
can be found in Figure S12, Tables S5 and S6.
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4. Biological Studies
4.1. Bacterial Strains and Growth Conditions
Four bacterial strains representing Gram-negative human pathogens Pseudomonas aeruginosa
strains PAO1, initially isolated from a wound [50] and FRD1, mucoid cystic fibrosis isolate [51])
and Gram-positive Staphylococcus aureus strain NRS70, methicillin resistant respiratory isolate [52]
and environmental isolate Bacillus aryabhattai SRP, were selected and tested. P. aeruginosa PAO1 and
FRD1 are well-established lab strains originally received from Washington State University repository.
S. aureus NRS70 was obtained from the NARSA repository. The identity of B. aryabhattai SRP isolate
was confirmed by 16S rRNA sequencing followed by phylogenetic analyses. The cultures were grown
in a 50% Brain Heart Infusion (BHI, for PAO1 and FRD1), 100% Tryptic soy broth (TSB) with 1% glucose
(for NRS70) and 100% BHI with 1% glucose (for SRP) media. All the strains were grown at 37 ◦ C.
4.2. Planktonic and Biofilm Growth Assessment
The 96-well plates pre-loaded with the mixtures of composite and Ag(I) cyanoximates or
chlorhexidine were sterilized by exposing to UV light for 10 min. The sterilization quality was controlled
by including a non-inoculated control. To minimize surface condensation and cross-contamination,
the lids of the 96-well plates were treated with 0.1% Triton-100 and dried prior to the UV treatment.
Both planktonic and biofilm modes of growth were quantitatively assayed. For this, prior to plate
inoculation, the cultures of PAO1 and FRD1, NRS70 and SRP were grown in 50% BHI, 100% TSB
with 1% glucose, 100% BHI with 1% glucose, respectively, to middle log phase as determined by the
individual growth curves and diluted to obtain absorbance at 600 nm of 0.1. These normalized cultures
were diluted 1:100 using saline (0.85% NaCl) and inoculated into the fresh corresponding medium in
96-well plates. The plates were incubated for 24 h at 37 ◦ C. The media were replaced with fresh sterile
media in 12 h of growth. To measure planktonic growth following the incubation, the cultures were
transferred into fresh 96-well transparent flat-bottom plates and OD600 was measured using a Biotek
Synergy HT microtiter plate reader (Tecan Instruments Inc., Mannedorf, Switzerland). The remaining
surface-associated cells (biofilms) were washed three times with saline (0.85% NaCl) to remove loosely
attached cells and stained with crystal violet (0.1%, w/v) for 10 min as described in Reference [53].
The dye was solubilized in 30% (v/v) acetic acid and 70% (v/v) ethanol and the absorbance of the
extracted crystal violet stain was measured at 595 nm. Non-inoculated wells were measured as blanks
and the corresponding measurements were subtracted from the rest of the data. Cells growing in
the wells containing no composite or composites alone were used as positive controls. The data
represent the mean values of seven technical replicates and two biological replicates. To consider
batch-to-batch variability, every experiment was repeated at least two times and only the consistent
data were considered for comparisons.
4.3. Scanning Electron Microscopy (SEM)
The inhibitory effect of Ag(PiCO)-yellow on four selected strains was studied by SEM. For this,
PAO1, FRD1, NRS70 and SRP were grown on the surface of composite alone or the mixture of composite
with 0.5–5% of Ag(PiCO)-yellow for 24 h at 37 ◦ C. The planktonic cultures were removed and the
surface-associated biofilms were rinsed with saline three times and fixed with 2% glutaraldehyde in
0.1 M sodium cacodylate, 9 mM CaCl2 for 2 h at room temperature. Following three washes with wash
buffer (60 mM sodium cacodylate, 180 mM sucrose), the samples were fixed with 1% OsO4 (aqueous)
for 1 h at room temperature, washed thrice again and dehydrated in ethanol (50%, 70%, 90%, 95% and
100% in 15 min steps). Then the samples were washed twice for 5 min each in hexamethyldisilaze
(HMDS) and were air-dried. The plate was trimmed and Au-Pd coated. SEM imaging was done by
using FEI Quanta 600 field emission SEM microscope available at the OSU Microscopy facility, with
the settings at 15–20 kV and spot size of 3.0. Some wells in the plate showed the phenomenon known
as ‘drift.’ Drift usually occurs when the sample is not adequately conductive. To overcome insufficient
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conductivity, we increased the thickness of the Au/Pd coating. However, some wells still showed drift
to the extent that imaging was impossible. To enable imaging for these wells, we decreased the dwell
time used in image capture from 30 microseconds to 3 microseconds.
4.4. A Combinatory Effect of Ag Compounds and Antibiotics
To test whether Ag compounds increase sensitivity to antibiotics, we tested Ag(PiCO)-yellow,
Ag(PiCO)-red and Ag(BTCO) in combination with tobramycin or trimethoprim, the antibiotics
commonly used to treat P. aeruginosa and S. aureus infections, respectively [54,55]. For this, we first
determined the sub-inhibitory concentrations of antibiotics that cause reduction but not a complete
inhibition of planktonic and biofilm growth of the pathogens. Then, 1% of overnight cultures with
OD600 of 0.1 were added to 200 µL of the respective media containing antibiotics in 96-well plate
(PAO1 and FRD1, 50% BHI with 0.5–6 µg/mL tobramycin; S. aureus, 100% TSB with 1% glucose
and 0.3–2.5 µg/mL trimethoprim; and B. aryabhattai, 100% BHI with 1% glucose and 0.125–2 µg/mL
kanamycin). Planktonic and biofilm growth was assayed as described above. Once, the sub-inhibitory
concentrations were determined, the bacterial strains were grown in 96 well plates pre-loaded with
the mixture of composite and selected Ag compounds and the corresponding medium: 50% BHI
(P. aeruginosa) or 100% TSB with 1% glucose (S. aureus), which contained the corresponding antibiotics:
tobramycin 0.5 µg/mL (P. aeruginosa), trimethoprim 1.25 µg/mL (S. aureus). Planktonic and biofilm
growth in the presence of the silver compounds and antibiotics was monitored and analyzed as
described above.
4.5. Durability Assessments
To determine the durability of the antibacterial effect of the Ag(PICO)-yellow, the cultures of
PAO1 and FRD1, NRS70 and SRP were grown in 50% BHI, 100% TSB with 1% glucose, 100% BHI
with 1% glucose, respectively and monitored for 6 days. The liquid cultures were collected for OD600
measurements every 12 h and replaced with sterile media. Biofilm growth was quantified at the end of
6-day incubation.
5. Results and Discussion
5.1. Chemical and Physical Studies
5.1.1. Synthesis and Characterization
Considering the current utmost importance of developing new compounds with antimicrobial
properties, here we synthesized and studied physical-chemical and antimicrobial properties of twelve
silver(I) cyanoximates. Twelve solid pure Ag(I) cyanoximates (including two polymorphs obtained for
the PiCO-system) of AgL composition (where L = cyanoximate anions from Scheme 1) were obtained
in 83–98% yield (Tables S3 and S4). Prepared solid Ag(I) complexes represent colored microcrystalline
powders (Figure 1). Their chemical composition was confirmed by elemental analyses for C, H,
N content. Furthermore, the compounds were characterized by recording their solid state IR and
electronic spectra (diffused reflectance) and data compared with those previously reported [43,47], thus
confirming their identity. More specifically, the IR spectra evidenced the formation of coordination
polymers in which the C-N-O fragment adopts the nitroso- character. Thus, typical for oximes ν(C=N)
and ν(N-O) frequencies are no longer identifiable but two new νas and νs bands between 1100 and
1300 cm−1 can be observed [56] (Figure S13). This indicates the re-distribution of electron density in
the fragment from the oxime- to nitroso-group that we observed previously.32,36 Electronic spectra of
solid Ag(I) cyanoximates contain typical for nitroso- complexes n→π* transitions around 380–560 nm
(Figures S14–16).
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metal complexes lowers the density of the polymeric material but increases its porosity. At this stage
we attribute observed effects to inhomogeneity of the obtained solid polymers most likely associated
with insufficient mixing procedures, rather than incompatible morphologies of Silver(I) coordination
polymer and acrylate composite. This finding is valuable because low porosity and small density
change of these new polymeric mixtures are necessary for the intended application as adhesives for
indwelling medical devices.
Pure acrylate polymeric composites represent rather hard and practically non-porous, fairly dense
materials. The introduction of silver(I) cyanoximate has led to the following changes:
(1)
(2)
(3)

Density of material became less;
Porosity of solid composite increases dramatically with addition of AgL;
Mechanical strength of material also significantly decreases.

Despite pronounced negative effects of “dilution” of a polymer composite with silver(I)
cyanoximates on its mechanical properties and strength, there are still good possibilities for use
of these antimicrobial compounds in medicine as adhesives for indwelling medical devices. The main
objective is that there are no such large forces in living bodies that need to withstand MPa pressures
and remaining intact. Real forces and pressures in living organisms are by order of magnitude smaller.
More detailed morphological and mechanical studies will be warranted and certainly conducted
when a bigger picture of antimicrobial effect of polymeric composites containing our silver(I) compounds
will emerge from studies that are currently underway.
5.1.5. Leaching of Silver Ions from Solid Supports
It was very important to investigate whether solid polymeric composite with embedded inorganic
Ag(I) coordination polymers are able to retain metal ions in the material. A significant presence of
silver ions in aqueous solutions is very undesirable due to two main factors: (1) excessive amount is
toxic; (2) removal of metal ions from the polymer will weaken its structure. Therefore, experiments on
determination of free silver(I) ions in aqueous solutions after exposure of polymeric composites to
water and buffers mimicking biological pH were warranted. To assess leaching of Ag+ ions, we selected
three Ag cyanoximates: Ag(CCO), Ag(ACO) and Ag(BTCO) complexes that were incorporated into
acrylamide polymer at 5% w/w concentrations as shown in (Figure S12, Tables S5 and S6). This choice
was based on the hydrophilicity of the corresponding cyanoxime and the overall water solubility
of the three AgL. The complexes Ag(CCO) and Ag(ACO) are sparingly soluble in water at elevated
temperatures (>70 ◦ C) but contain water soluble cyanoximes, while both Ag(BTCO) and its ligand
precursor HBTCO are not soluble in water. Thus, the selected three cyanoximates cover a large
spectrum of solubility and affinity to water for both components of the AgL: the ligand and the complex.
As a control, a water-soluble silver(I) nitrate was used and incorporated into the solid matrix in a
similar fashion. The concentration of Ag+ ions in solutions (two non-halogenated buffers TRIS and
MOPS and in pure water) was monitored by the ICP method.
As expected, the control solid polymer containing water-soluble AgNO3 showed a significant
leaching of Ag+ ions from its solid matrix (Figure S17). In this case, 32.1% of silver was released into
water and 40.9% and 47.7% of silver leached into TRIS and MOPS buffers, respectively. To the contrary,
leaching of Ag+ from the composites containing Ag(CCO), Ag(ACO) and Ag(BTCO) was below
0.2 ppm when monitored during over 150 h. Thus, the Ag(I) cyanoximates tested in the experiment
did not to release any significant amounts of Ag+ from polymeric matrixes into the solutions of TRIS,
MOPS buffers and DDI-water. These non-halogenated buffers had little effect on leaching of Ag+ ,
presumable due to the significant thermodynamic stability of the starting coordination-polymeric Ag(I)
cyanoximates. Indeed, all studied in this project AgL represent coordination polymers of different
complexity, where the cyanoxime groups act as bridging ligands by means of the N- and O-atoms of
the nitroso-groups and also using the CN-group as well. Nevertheless, monitoring of the leaching
over the period of one week showed a very small leaching effect in the buffer solutions (both TRIS
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5.2. Biological Studies
Prior to microbiological studies it was important to determine whether Silver(I) coordination
polymers used in this work possess toxic properties for cells. Hence, we performed series in vitro
cytotoxicity experiments to evaluate complexes’ effect on cells viability, which are summarized in
Figure S22. No apparent cells toxicity was observed which allowed further investigations of solid
polymers containing AgL for intended possible applications such as: (1) antimicrobial additives to
adhesives for indwelling devices; (2) antimicrobial and biofilm inhibiting polymers for coating.
5.2.1. Ag(I) Cyanoximates Inhibit Planktonic Growth of Gram-Positive and Gram-Negative Bacteria
To assess the bacteriostatic effect of the newly synthesized silver complexes, first we characterized
the effect of all twelve compounds (Ag(ECO), Ag(ACO), Ag(BCO), Ag(CCO), Ag(BOCO), Ag(BiMCO),
Ag(BiHCO), Ag(PiCO), Ag(MCO), Ag(PiPCO), Ag(BTCO) and Ag(PiCO) yellow and red forms) on
planktonic growth of selected bacterial strains. We also included chlorhexidine, a cationic polybiguanide
(bisbiguanide), commonly used to treat gingivitis and periodontitis, as a reference compound [49].
Three human pathogens, including two strains of P. aeruginosa, PAO1 (wound isolate) [50] and
FRD1 (mucoid cystic fibrosis isolate) [51] and S. aureus strain NRS70 (methicillin resistant respiratory
isolate) [52], representing different infection profiles, were selected for testing. Both P. aeruginosa and
S. aureus are becoming increasingly resistant to currently available antibiotics [58,59]. In addition,
we used an environmental isolate identified as Bacillus aryabhattai SRP based on sequencing of its
PCR-amplified 16S rRNA gene (data not shown). Quantitative assessment of planktonic growth
showed that eight compounds inhibited growth of all four tested organisms (Table 3).
Table 3. The concentrations of the tested silver(I) cyanoximates embedded into polymeric composite
that inhibited planktonic growth. The lowest inhibiting concentrations (0.5%) are shown in bold.
Chlorhexidine was used as a reference compound.
PLANKTONIC

S. aureus

B. aryabhattai

PAO1

FRD1

Ag(ECO)
Ag(ACO)
Ag(BCO)
Ag(CCO)
Ag(BOCO)
Ag(BIMCO)
Ag(BIHCO)
Ag(PiCO) yellow
Ag(PiCO) red
Ag(BTCO)
Ag(MCO)
Ag(PiPCO)

0.5%
1%
1%
0.5%
1%
2.5%
5%
2.5%
>5%
5%
1%
1%

5%
2.5%
>5%
>5%
5%
5%
>5%
5%
2.5%
>5%
1%
1%

1%
1%
5%
1%
1%
5%
5%
0.5%
1%
2.5%
0.5%
0.5%

1%
2.5%
0.5%
1%
1%
2.5%
>5%
0.5%
2.5%
2.5%
0.5%
0.5%

Chlorhexidine

0.5%

0.5%

2.5%

1%

The most efficient inhibition was observed against P. aeruginosa strains FRD1 and PAO1. Five
compounds including Ag(BCO), Ag(PiCO), Ag(PiCO) yellow, Ag(MCO) and Ag(PiPCO) inhibited
growth of at least one of the two strains at the lowest tested concentration of 0.5%. Two compounds
Ag(ECO) and Ag(CCO) were similarly active against S. aureus. The isolate of B. aryabhattai SRP showed
the overall highest resistance to the tested silver compounds.
The most significant inhibition of the SRP strain was registered at 1% for Ag(MCO) and Ag(PiPCO).
Based on all four strains, we concluded that the most efficient compounds were Ag(PiCO), Ag(PiCO)
yellow, Ag(MCO) and Ag(PiPCO). Overall, the cyanoximates showed the highest efficiency against
P. aeruginosa, whereas B. aryabhattai showed more resistance. This may be due to the differences in the
structure between Gram-negative and Gram-positive cell walls, elevated resistance of environmental
bacteria and/or different modes of action of the tested cyanoximates.
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Variability in the antimicrobial activity of silver compounds was anticipated based on our earlier
report for Ag(MCO) and Ag(PiPCO) [45], as well as previously reported strain specificity of the
antimicrobial effect of silver nanoparticles (AgNPs) [60]. The latter were tested against four strains of
Gram-negative Escherichia coli and Gram-positive two strains of B. subtilis and three strains of S. aureus.
However, in this case, B. subtilis strains showed the highest sensitivity for AgNPs, suggesting potential
differences in the mechanisms of action between silver cyanoximates and AgNPs.
5.2.2. Silver(I) Cyanoximates Inhibit Biofilm Growth of Gram Positive and Gram Negative Bacteria
It has been observed that silver effectively exerts antimicrobial effect against planktonic cells of
diverse bacterial species [61,62] but is much less effective against biofilm cells [63]. Similar observations
were made for AgNPs and ions tested against planktonic and biofilm cells of P. aeruginosa [64,65]
and Escherichia coli [66]. Bacterial biofilms are well known to be more resistant than their planktonic
counterparts. Once developed, biofilm infections are difficult to treat, mostly due to poor antibiotic
penetration, slow growth, adaptive stress responses and the formation of persister cells. Further
complication is the development of multi-species infections, where diverse pathogens express multiple
different mechanisms of resistance. This makes it more difficult to devise the suitable interventions and
the development of new anti-biofilm implant materials [67]. These highly resistant biofilm infections
cost the healthcare industry more than $1 billion annually, as the only currently available effective
treatment is a long-term high-dose antibiotic treatment along with removal of the infected device.
To estimate the potential anti-biofilm effect of the synthesized silver complexes, we assessed their
inhibitory effect on biofilm growth of the selected bacterial strains. It was expected that biofilms
would show higher resistance to the compounds than the corresponding planktonic cultures. This
was true for several cases, including Ag(MCO) and Ag(PiPCO), for which biofilms of at least three
bacterial strains showed higher resistance (Table 4). However, the results for other compounds were
strain specific, ranging from showing similar inhibitory effects against both planktonic and biofilm
cells to being more efficient against biofilm cells. For example, Ag(BTCO) showed similar inhibitory
effects against planktonic and biofilm cultures of S. aureus and P. aeruginosa but a significantly higher
inhibitory effect (no growth at 0.5%) for B. aryabhattai.
Table 4. The concentrations of the tested silver(I) cyanoximates embedded into polymeric composite that
inhibited biofilm growth. The lowest inhibiting concentrations (0.5%) are shown in bold. Chlorhexidine
was used as a reference compound.
BIOFILM

S. aureus

B. aryabhattai

PAO1

FRD1

Ag(ECO)
Ag(ACO)
Ag(BCO)
Ag(CCO)
Ag(BOCO)
Ag(BIMCO)
Ag(BIHCO)
Ag(PiCO) yellow
Ag(PiCO) red
Ag(BTCO)
Ag(MCO)
Ag(PiPCO)

1%
1%
5%
5%
1%
5%
0.5%
2.5%
2.5%
5%
5%
2.5%

5%
2.5%
2.5%
>5%
>5%
2.5%
5%
2.5%
2.5%
0.5%
1%
2.5%

1%
2.5%
5%
2.5%
0.5%
1%
>5%
0.5%
1%
2.5%
1%
1%

0.5%
2.5%
2.5%
>5%
2.5%
0.5%
0.5%
0.5%
1%
2.5%
>5%
>5%

Chlorhexidine

0.5%

0.5%

>5%

2.5%
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Overall, the most stable inhibition against biofilms of all four bacteria was observed for both
yellow and red forms of Ag(PiCO) inhibiting biofilm growth in the range of 0.5 to 2.5% (Table 4).
The apparent higher sensitivity of biofilms to some compounds is likely because the compounds
were embedded into the substratum and prevented cell adhesion and therefore biofilm development
as opposed to showing activity against developed biofilms. Interestingly, although chlorhexidine
showed the highest efficiency against S. aureus and B. aryabhattai, it was not as efficient against
biofilms of P. aeruginosa strains. Chlorhexidine, is a quaternary ammonium compound disrupting
cell membrane and ultimately causing cell lysis and loss of cellular components [68]. The inability of
chlorhexidine to inhibit P. aeruginosa strains is likely due to the up-regulation of RND-type multidrug
efflux pumps together with down-regulation of genes encoding proteins involved in electron transport
and membrane transport [69].
5.2.3. Ag(PiCO)-Yellow Prevents Biofilm Formation Shown by Scanning Electron Microscopy (SEM)
In order to validate the inhibitory effect of Ag compounds on biofilm development, we performed
scanning electron microscopy (SEM) of biofilms grown in the presence of Ag(PiCO)-yellow, one the
most efficient compounds. For this, we applied three concentrations of the compound: 0.5%; 2.5%; or
5%, inhibiting biofilm development of, respectively; P. aeruginosa, S. aureus and B. aryabhattai; or all
four strains. As a control, we observed the biofilm architecture and cell morphology in the samples
grown on the surface of composite alone. All tested strains (P. aeruginosa PAO1 and FRD1, S. aureus and
B. aryabhattai) formed uniform biofilms when grown on composite material with no Ag(PiCO)-yellow
(Figure 6). In agreement with the biofilm growth experiments described above, the presence of 0.5%
AgPiCO yellow practically abolished biofilm formation in P. aeruginosa strains PAO1 and FRD1. Only
single cells or small cell clusters were detected on the treated surfaces. Similarly, the addition of 2.5%
Ag(PiCO)- yellow prevented biofilm development of S. aureus and B. aryabhattai strains. The presence
of 5% of the compounds completely prevented cell adhesion and no cells were observed on the treated
surfaces (Figure 6).
It has been previously shown that silver ions destabilize the structures of the S. epidermidis
biofilms likely by reducing the number of binding sites for hydrogen bonds and electrostatic and
hydrophobic interactions [63]. Here we demonstrate that the biofilm development of two major
antibiotic resistant pathogens P. aeruginosa and S. aureus, as well as environmental strain of B. aryabhattai
can be significantly reduced or completely prevented by addition of 0.5 to 5% of at least one Ag(I)
cyanoximate, Ag(PiCO)-yellow.
The antimicrobial activity of the studied compounds may rely on the release of Ag ions as
was shown for other Ag-containing compounds [70,71]. It is likely that the newly synthesized
cyanoximates serve as a vehicle delivering biologically-active Ag ions to bacterial cells. Further
research is needed to study the interactions between selected cyanoximates and bacterial cells and
human tissues. Development of more active compounds will further reduce the required dose and
may enable their broad applications as additives to prosthetic glues or dental materials.
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re-occur on the surface of Ag(PiCO)-yellow-loaded composites after removing the previously grown
culture by washing, sonicating and 97% ethanol treatment. However, sequential inoculations showed
a minor increase in growth (data not shown). SEM analysis showed that the composites remained
covered with the biomass, which likely shielded the antibacterial effect of Ag(PiCO)-yellow from
the newly inoculated cells and provided support for their initial attachment and biofilm formation
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(data not shown). It is also possible that the remaining cells prevented the release of Ag ions and
therefore diminished the antibacterial effect of the AgL. Further work will aim to further optimize the
composition of the compounds that would further increase their antimicrobial properties and durability.
5.2.5. Synergistic Effect of Ag(PiCO)-Red and Ag(BTCO) and Antibiotics
Since all available antibiotics are quickly becoming obsolete due to increasing bacterial resistance,
there is a pressing need for combinatorial therapies, which would combine the application of antibiotics
and the compounds sensitizing cells or preventing development of resistance, thus enabling efficient
application of currently available antibiotics. Earlier studies suggested that Ag compounds have a
synergistic effect with conventional antibiotics [70,72].
We tested whether the presence of selected Ag(I) cyanoximates would increase susceptibility
to antibiotics of the studied pathogens (Figure 7). For this, we chose antibiotics that are commonly
used against the respective bacteria and determined their sub-inhibitory concentrations. The latter
were defined as the concentrations reducing but not fully inhibiting planktonic and biofilm growth of
the corresponding bacterial strains. Based on planktonic and biofilm growth data, we estimated the
sub-inhibitory concentrations of the antibiotics as follows: PAO1 and FRD1, 0.5 µg/mL tobramycin;
S. aureus, 0.625 µg/mL trimethoprim; and B. aryabhattai, 0.125 µg/mL kanamycin. These concentrations
were applied during growth of the bacterial strains in the presence of one of three silver compounds
selected for this experiment, Ag(PiCO)-red, Ag(PiCO)-yellow and Ag(BTCO). Planktonic and biofilm
growth was monitored and showed that the presence of Ag(PiCO)-red and Ag(BTCO) increased
antibiotic susceptibility in both P. aeruginosa strains (Figure 7) but not in S. aureus and B. aryabhattai
strains (data not shown). In FRD1, the combination of 0.5 µg/mL tobramycin and 0.5% Ag(PiCO)-red
completely inhibited both planktonic and biofilm growth, whereas the presence of the antibiotic alone
only slightly reduced growth. A similar trend was observed for 1% Ag(BTCO) in FRD1 and 0.5%
Ag(BTCO) in PAO1. It was difficult to observe such effect at 1% Ag(PiCO)-red in PAO1, as almost
no growth was observed at this condition. For the same reason, the effect Ag(PiCO)-yellow was not
detected as it inhibited growth of PAO1 and FRD1 at 0.5%, the lowest tested condition (Tables 3 and 4).
Combining Ag-based antimicrobials with other compounds with the aim to increase their efficacy
have been previously proposed and tested in several studies. For example, combination of silver
sulfadiazine with nitric oxide showed a synergistic effect against a wide range of bacterial pathogens
causing wounds infection [73]. Storm et al used silver nitrate and nitric oxide combined together in a
multilayered silica based xerogels and observed synergistic inhibition of P. aeruginosa and S. aureus
attachment to the implant surface and enhanced the bacterial killing [74]. The presence of the ionic
silver was also shown to enhance antibacterial properties of hydrogen peroxide against P. aeruginosa
biofilms [75]. Chemically conjugated antibiotics with AgNPs enhanced the antibacterial effect of
the antibiotics [76,77]. In our study, the increased sensitivity of P. aeruginosa to tobramycin, when
applied in combination with Ag(PiCO)-red and Ag(BTCO), provides a potential for preventative and
therapeutic treatment against P. aeruginosa biofilm infections. Using such combinatorial therapy will
enable application of lower doses of antibiotics, which would reduce the overall toxicity and slow
down the development of antibiotic resistance.
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6. Conclusions

Here we report the inhibiting effects of several silver cyanoximates against both Gram-positive
and Gram-negative bacteria but particularly against two human pathogens, P. aeruginosa and S. aureus,
suggesting that they can be used as efficient antimicrobials. In this initial “proof-of-concept study”
detailed conclusions are as follows:
•

Preparation of visible light insensitive, thermally stable and poorly water soluble Ag(I)
cyanoximates presents a high yield one-step reaction at room temperature from respective
cyanoximes and AgNO3 in aqueous solutions.
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The tested Ag(I) cyanoximates showed a significant thermal stability upon heating up to
~140 ◦ C. Similar thermal stability was also found for the solid polymeric materials containing
Ag(I) complexes, which is important for thermal sterilization purpose in their intended
practical applications.
The compounds demonstrate excellent tolerance to components of the light-curable polymeric
composite and can be embedded into it at variable by weight concentrations from 0.5 to 5%. This
is despite the presence of electron rich groups in ingredients of the composite mixture.
Formed viscous, flowable polymeric composites containing AgL can be poured or casted into
desired spaces and forms – well plates, plastic or rubber vials and vessels – and then successfully
cured in them to a solid state by commercially available dental light source.
The Ag(I) cyanoximates did not significantly leached out of polymeric matrices, which enables
their applications in antimicrobial coating of surfaces.
Introduction of solid silver complexes leads to the less dense final polymeric materials.
Porosity of solid composites increases with addition of solid AgL into the polymer.
Mechanical strength of cured solid acrylate composite significantly decreases when solid AgL are
embedded into the polymer.
The compounds showed significant antimicrobial effect against both planktonic and biofilm growth
of Gram-positive and Gram-negative bacterial pathogenic and environmental strains. Importantly,
selected compounds caused a synergistic effect when added together with conventional antibiotics.
These results indicate a high potential for these compounds to be used as antimicrobials or as
potentiates of antibiotics.
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